Format

Send to

Choose Destination
Transpl Infect Dis. 2011 Apr;13(2):117-21. doi: 10.1111/j.1399-3062.2010.00561.x. Epub 2010 Aug 29.

Treatment of respiratory syncytial virus infection in adult patients with hematologic malignancies based on an institution-specific guideline.

Author information

1
Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Hackensack, New Jersey, USA. dmccoy@humed.com

Abstract

A total of 26 adults with hematologic malignancies and/or hematopoietic stem cell transplant were treated for respiratory syncytial virus (RSV) infection based on an institutional guideline. Thirteen patients received aerosolized ribavirin, and 13 received aerosolized ribavirin and intravenous palivizumab. Two deaths, not attributed to RSV infection, occurred within 90 days of diagnosis.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center